These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 38046334)
41. Glucose/Glutathione Co-triggered Tumor Hypoxia Relief and Chemodynamic Therapy to Enhance Photothermal Therapy in Bladder Cancer. Chen WH; Yu KJ; Jhou JW; Pang HH; Weng WH; Lin WS; Yang HW ACS Appl Bio Mater; 2021 Oct; 4(10):7485-7496. PubMed ID: 35006706 [TBL] [Abstract][Full Text] [Related]
42. Low Power Single Laser Activated Synergistic Cancer Phototherapy Using Photosensitizer Functionalized Dual Plasmonic Photothermal Nanoagents. Younis MR; Wang C; An R; Wang S; Younis MA; Li ZQ; Wang Y; Ihsan A; Ye D; Xia XH ACS Nano; 2019 Feb; 13(2):2544-2557. PubMed ID: 30730695 [TBL] [Abstract][Full Text] [Related]
44. Black-Phosphorus-Incorporated Hydrogel as a Sprayable and Biodegradable Photothermal Platform for Postsurgical Treatment of Cancer. Shao J; Ruan C; Xie H; Li Z; Wang H; Chu PK; Yu XF Adv Sci (Weinh); 2018 May; 5(5):1700848. PubMed ID: 29876210 [TBL] [Abstract][Full Text] [Related]
45. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy. Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673 [TBL] [Abstract][Full Text] [Related]
46. Targeted Delivery of Functionalized Upconversion Nanoparticles for Externally Triggered Photothermal/Photodynamic Therapies of Brain Glioblastoma. Tsai YC; Vijayaraghavan P; Chiang WH; Chen HH; Liu TI; Shen MY; Omoto A; Kamimura M; Soga K; Chiu HC Theranostics; 2018; 8(5):1435-1448. PubMed ID: 29507632 [TBL] [Abstract][Full Text] [Related]
47. Targeting the tumor microenvironment with amphiphilic near-infrared cyanine nanoparticles for potentiated photothermal immunotherapy. Noh I; Son Y; Jung W; Kim M; Kim D; Shin H; Kim YC; Jon S Biomaterials; 2021 Aug; 275():120926. PubMed ID: 34147723 [TBL] [Abstract][Full Text] [Related]
48. MnO Li B; Wang X; Hong S; Wang Q; Li L; Eltayeb O; Dong C; Shuang S Food Funct; 2021 Jul; 12(14):6334-6347. PubMed ID: 34100053 [TBL] [Abstract][Full Text] [Related]
49. Molecularly Targeted Photothermal Ablation of Epidermal Growth Factor Receptor-Expressing Cancer Cells with a Polypyrrole-Iron Oxide-Afatinib Nanocomposite. Rethi L; Mutalik C; Rethi L; Chiang WH; Lee HL; Pan WY; Yang TS; Chiou JF; Chen YJ; Chuang EY; Lu LS Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291827 [TBL] [Abstract][Full Text] [Related]
50. Li C; Yang XQ; Zhang MZ; Song YY; Cheng K; An J; Zhang XS; Xuan Y; Liu B; Zhao YD Theranostics; 2018; 8(20):5662-5675. PubMed ID: 30555572 [TBL] [Abstract][Full Text] [Related]
51. Multifunctional AuPt Nanoparticles for Synergistic Photothermal and Radiation Therapy. Tang H; Chen J; Qi LH; Lyu M; Quan H; Tan ZJ Int J Nanomedicine; 2023; 18():6869-6882. PubMed ID: 38026515 [TBL] [Abstract][Full Text] [Related]
52. Targeting acute myeloid leukemia cells by CD33 receptor-specific MoS Štefík P; Annušová A; Lakatoš B; Elefantová K; Čepcová L; Hofbauerová M; Kálosi A; Jergel M; Majková E; Šiffalovič P Biomed Mater; 2021 Aug; 16(5):. PubMed ID: 34280914 [TBL] [Abstract][Full Text] [Related]
53. AS1411-conjugated doxorubicin-loaded silver nanotriangles for targeted chemo-photothermal therapy of breast cancer. Li F; Cao Y; Kan X; Li D; Li Y; Huang C; Liu P Nanomedicine (Lond); 2023 Jul; 18(17):1077-1094. PubMed ID: 37650546 [TBL] [Abstract][Full Text] [Related]
54. Cancer Therapeutic Targeting of Hypoxia Induced Carbonic Anhydrase IX: From Bench to Bedside. McDonald PC; Chafe SC; Supuran CT; Dedhar S Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884358 [TBL] [Abstract][Full Text] [Related]
55. PEGylated hydrazided gold nanorods for pH-triggered chemo/photodynamic/photothermal triple therapy of breast cancer. Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y Acta Biomater; 2018 Dec; 82():171-183. PubMed ID: 30336271 [TBL] [Abstract][Full Text] [Related]
56. Quantitative Imaging of the Hypoxia-Related Marker CAIX in Head and Neck Squamous Cell Carcinoma Xenograft Models. Huizing FJ; Hoeben BAW; Franssen GM; Boerman OC; Heskamp S; Bussink J Mol Pharm; 2019 Feb; 16(2):701-708. PubMed ID: 30550290 [TBL] [Abstract][Full Text] [Related]
57. Tumour-homing chimeric polypeptide-conjugated polypyrrole nanoparticles for imaging-guided synergistic photothermal and chemical therapy of cancer. Sun M; Guo J; Hao H; Tong T; Wang K; Gao W Theranostics; 2018; 8(10):2634-2645. PubMed ID: 29774064 [TBL] [Abstract][Full Text] [Related]
58. A biomimetic nanoplatform for precise reprogramming of tumor-associated macrophages and NIR-II mediated antitumor immune activation. Du Y; Qian X; Lin F; Gao B; Wang W; Yang H; Wang W; Ding Y Acta Biomater; 2023 May; 162():85-97. PubMed ID: 36948328 [TBL] [Abstract][Full Text] [Related]
59. Targeted co-delivery of curcumin and erlotinib by MoS Chen Z; Wei X; Zheng Y; Zhang Z; Gu W; Liao W; Zhang H; Wang X; Liu J; Li H; Xu W J Nanobiotechnology; 2023 Sep; 21(1):333. PubMed ID: 37717020 [TBL] [Abstract][Full Text] [Related]